These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28002117)

  • 1. Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers.
    Georgiou L; Penny J; Nicholls G; Woodhouse N; Blé FX; Hubbard Cristinacce PL; Naish JH
    Invest Radiol; 2017 Feb; 52(2):111-119. PubMed ID: 28002117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Gadoxetate Liver Uptake and Efflux Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging Enables Preclinical Quantification of Transporter Drug-Drug Interactions.
    Georgiou L; Penny J; Nicholls G; Woodhouse N; Blé FX; Naish JH; Hubbard Cristinacce PL
    Invest Radiol; 2018 Sep; 53(9):563-570. PubMed ID: 29771727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
    Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
    Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
    Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
    J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography: prospective comparison of patients with normal gallbladder function and acute cholecystitis.
    Yacoub JH; Yousuf A; Agrawal G; Thomas S; Appelbaum DE; Oto A
    Acta Radiol; 2015 Jul; 56(7):782-9. PubMed ID: 25009279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion.
    Ringe KI; Hinrichs J; Merkle EM; Weismüller TJ; Wacker F; Meyer BC
    J Magn Reson Imaging; 2014 Jul; 40(1):106-12. PubMed ID: 24923477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
    Giraudeau C; Leporq B; Doblas S; Lagadec M; Pastor CM; Daire JL; Van Beers BE
    Eur Radiol; 2017 May; 27(5):1804-1811. PubMed ID: 27553933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional MR cholangiography of the cystic duct and sphincter of Oddi using gadoxetate disodium: is a 30-minute delay long enough?
    Corwin MT; Lamba R; McGahan JP
    J Magn Reson Imaging; 2013 Apr; 37(4):993-8. PubMed ID: 23001618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
    Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
    Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of gadoxetate biliary transit time in determining hepatocyte function.
    Wu J; Li H; Lin Y; Chen Z; Zhong Q; Gao H; Fu L; Sandrasegaran K
    Abdom Imaging; 2015 Jan; 40(1):95-101. PubMed ID: 25056714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compressed Sensing and Parallel Imaging for Double Hepatic Arterial Phase Acquisition in Gadoxetate-Enhanced Dynamic Liver Magnetic Resonance Imaging.
    Yoon JK; Kim MJ; Lee S
    Invest Radiol; 2019 Jun; 54(6):374-382. PubMed ID: 30724814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibition.
    Ulloa JL; Stahl S; Yates J; Woodhouse N; Kenna JG; Jones HB; Waterton JC; Hockings PD
    NMR Biomed; 2013 Oct; 26(10):1258-70. PubMed ID: 23564602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of gadoxetate disodium-enhanced MR cholangiography in chronic cholestatic biliary disease.
    Kühn JP; Spoerl M; Nassif A; Mester M; Weitschies W; Siegmund W; Hosten N; Mensel B
    Clin Radiol; 2014 Oct; 69(10):1027-33. PubMed ID: 24957855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma.
    Schalkx HJ; van Stralen M; Coenegrachts K; van den Bosch MA; van Kessel CS; van Hillegersberg R; van Erpecum KJ; Verkooijen HM; Pluim JP; Veldhuis WB; van Leeuwen MS
    Eur Radiol; 2014 Sep; 24(9):2146-56. PubMed ID: 24996795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Dynamic Hepatic Magnetic Resonance Imaging Strategy Using Advanced Parallel Acquisition, Rhythmic Breath-Hold Technique, and Gadoxetate Disodium Enhancement.
    Fahlenkamp UL; Wagner M; Nickel D; Adam U; Krueger K; Taupitz M; Schwenke C; Huppertz A
    Invest Radiol; 2016 Jan; 51(1):33-40. PubMed ID: 26322554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
    Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
    AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
    Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
    Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver enhancement in healthy dogs after gadoxetic acid administration during dynamic contrast-enhanced magnetic resonance imaging.
    Borusewicz P; Stańczyk E; Kubiak K; Spużak J; Glińska-Suchocka K; Jankowski M; Nicpoń J; Podgórski P
    Vet J; 2018 May; 235():16-21. PubMed ID: 29704934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
    Yamada A; Hara T; Li F; Fujinaga Y; Ueda K; Kadoya M; Doi K
    Radiology; 2011 Sep; 260(3):727-33. PubMed ID: 21712472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.